Patent directory · USPTO A61K / A61P
Patents matching “antibody”
426 pharma patents match "antibody" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 426 pharmaceutical patents matching "antibody" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7342105
Antibody and use thereof
granted -
US 7335477
Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines
granted -
US 7332585
Bispecific single chain Fv antibody molecules and methods of use thereof
granted -
US 7285639
Antibody to telomerase reverse transcriptase
granted -
US 7256004
Variants of humanized anti-carcinoma monoclonal antibody CC49
granted -
US 7247303
Selected antibody CDRs for binding to aminophospholipids
granted -
US 7173112
Antibody to GALP and uses thereof
granted -
US 7153509
Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
granted -
US 7094883
Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
granted -
US 7094405
Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients
granted -
US 7056509
Antibody methods for selectively inhibiting VEGF
granted -
US 6889145
Three-dimensional model of a Fc region of an IgE antibody and uses thereof
expired -
US 6887468
Antibody kits for selectively inhibiting VEGF
expired -
US 6818749
Variants of humanized anti carcinoma monoclonal antibody cc49
expired -
US 6703020
Antibody conjugate methods for selectively inhibiting VEGF
expired -
US 6699674
Expression and refolding of truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi and its use in antibody based detection assays and vaccines
expired -
US 6689362
Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)
expired -
US 6676941
Antibody conjugate formulations for selectively inhibiting VEGF
expired -
US 6573236
Inhibiting MOG-antibody binding
expired -
US 6573058
Antibody to herpes virus entry receptor protein
expired -
US 6569431
Recombinant antibody fragments as autoantibody antagonists
expired -
US 6524583
Antibody methods for selectively inhibiting VEGF
expired -
US 6482415
Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi and its use in antibody based detection assays and vaccines
expired -
US 6416758
Antibody conjugate kits for selectively inhibiting VEGF
expired